Rezolute, Inc.
RZLT · NASDAQ
Bulios Fair Price
$2.74
35.1% downside
Trenutna cena
$4.22
Po podatkih Bulios Fair Price je delnica RZLT trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Rezolute, Inc. (RZLT) is a biotechnology company specializing in the development of therapeutics to improve the lives of patients suffering from metabolic disorders and endocrine disorders. Headquartered in the United States, the company focuses on researching and developing new treatment approaches and therapies for patients with type 1 diabetes and other health issues. The company concentrates on innovations in pharmacology and therapeutic methods, working to create new drugs that can enhance the quality of life for affected patients. Shares of Rezolute, Inc. (RZLT) can be an appealing choice for investors seeking investment opportunities in the biotechnology and healthcare research sector.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Nevan Charles Elam
Employees
68
Headquarters
Redwood City
Prihajajoči dogodki
Earnings
Upcoming earnings report
Earnings
Upcoming earnings report